Ocutrx Technologies Expands Scientific Advisory Board with Appointment of Dr. Robert Louis
Neurosurgeon ascends to the scientific advisory board of Ocutrx, a leading company.
Ocutrx Technologies, a leading player in augmented reality (AR) and 3D visualization technology, has announced the expansion of its Scientific Advisory Board with the appointment of Dr. Robert Louis, a prominent neurosurgeon. Dr. Louis, Director of the Skull Base and Pituitary Tumor Program at Hoag Memorial Hospital Presbyterian in Newport Beach, California, brings extensive expertise in intraoperative AR/VR imaging to the table.
This strategic move aims to extend Ocutrx’s flagship DigiLoupes system beyond its existing orthopedic and spinal uses into complex brain and neurosurgery procedures such as tumor resection, spinal disorder treatment, and neurological condition management like epilepsy and hydrocephalus.
With Dr. Louis on board, Ocutrx Technologies hopes to broaden the application of its DigiLoupes technology to delicate neurosurgical procedures. This collaboration is expected to significantly influence the development of next-generation visualization tools that enhance surgical clarity, precision, and efficiency in neurosurgery.
The impact of this development includes improved patient outcomes through enhanced imaging and visualization during brain and spinal surgeries. It also promotes innovation in surgical technology by integrating cutting-edge AR capabilities driven by clinical insight from Dr. Louis’s experience.
This collaboration signals a notable advancement in combining AR with neurosurgery, potentially setting new standards for surgical precision and minimally invasive techniques in the neurosciences.
Dr. Louis is deeply committed to training the next generation of surgeons and reimagining the OR of tomorrow. He has published extensively and lectures worldwide on advanced neurosurgical techniques, AR/VR integration, and the future of digital surgery. Dr. Louis has long championed the use of emerging technologies, including intraoperative AR/VR imaging, in brain and spine surgery.
Michael Freeman, CEO/CTO and Founder of Ocutrx, stated that Dr. Louis's leadership will be invaluable in developing next-generation visualization tools. His expertise will help shape DigiLoupes for delicate procedures such as brain tumor resection, treatment of spinal disorders, and management of neurological conditions like epilepsy and hydrocephalus.
Dr. Robert Louis, MD, FAANS, FCNS, joins Ocutrx Technologies' Scientific Advisory Board with a reputation as an internationally recognized pioneer in minimally invasive and endoscopic neurosurgery. His appointment is a testament to Ocutrx's commitment to advancing the field of neurosurgery through the integration of innovative technology.
This development marks an exciting step forward in the integration of AR technology in neurosurgery, and it will be interesting to see how this collaboration shapes the future of neurosurgical procedures.
